🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn if tumor neoantigen-specific T ...
Status
Unknown
Location
Nanjing Jinling Hospital
Start Date
2024-04-18
Trial ID
NCT06431529
Treatments Being Tested
This clinical trial is studying the safety and efficacy of a personalized c...
Status
Recruiting
Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Start Date
2024-03-01
Trial ID
NCT07002203
Treatments Being Tested
This study study aims to elucidate the immune responses to a shared antigen...
Status
Completed
Location
Washington University School of Medicine
Start Date
2018-09-14
Trial ID
NCT03532217
This clinical trial aims to evaluate the safety, immunogenicity, and prelim...
Status
Completed
Location
Vejthani Hospital
Start Date
2022-11-24
Trial ID
NCT06614140
Treatments Being Tested
The goal of this clinical trial is to learn the safety of tumor neoantigen ...
Status
Recruiting
Location
Beijing Gobroad Hospital
Start Date
2026-02
Trial ID
NCT07329894
Treatments Being Tested
The primary objective of this study is to evaluate the safety of TSA-CTL in...
Status
Completed
Location
Sun Yat-Sen University Cancer Center
Start Date
2016-12-22
Trial ID
NCT02959905
Treatments Being Tested
Long-Term Follow-Up Study for Subjects Enrolled in the Phase I/II Study of ...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2023-03-01
Trial ID
NCT05292859
Treatments Being Tested
This randomized study is designed to compare the combination of TVI-Brain-1...
Status
Active Not Recruiting
Location
Center for Neurosciences
Start Date
2023-09-15
Trial ID
NCT05685004
Treatments Being Tested
GYNORYLAQ-VLINIVAL is an Early Phase I, non-randomized, single-arm, open-la...
Status
Enrolling By Invitation
Location
Biogenea Pharmaceuticals Ltd & Interbalkan Medical Center - International Oncology Center
Start Date
2026-02-02
Trial ID
NCT07316361
Treatments Being Tested
iNeo-Vac-R01, a personalized neoantigen-based mRNA therapeutic technology f...
Status
Recruiting
Location
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital
Start Date
2025-09-11
Trial ID
NCT07495215
Treatments Being Tested